{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:48:57Z","timestamp":1790516937119,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/mmy\/myx064","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T15:11:32Z","timestamp":1502291492000},"page":"469-478","source":"Crossref","is-referenced-by-count":35,"title":["Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis"],"prefix":"10.1093","volume":"56","author":[{"given":"Wendy","family":"Kloezen","sequence":"first","affiliation":[{"name":"ErasmusMC Department of Medical Microbiology and Infectious Diseases Wytemaweg 80 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florianne","family":"Parel","sequence":"additional","affiliation":[{"name":"ErasmusMC Department of Medical Microbiology and Infectious Diseases Wytemaweg 80 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Br\u00fcggemann","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre Pharmacy PO BOX 9101 6500 HB Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Asouit","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre Pharmacy PO BOX 9101 6500 HB Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Helvert-van Poppel","sequence":"additional","affiliation":[{"name":"St Elisabeth Ziekenhuis Department of clinical pathology Hilvarenbeekseweg 60 5022 GC Tilburg, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fahal","sequence":"additional","affiliation":[{"name":"Mycetoma Research Centre Khartoum Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Mouton","sequence":"additional","affiliation":[{"name":"ErasmusMC Department of Medical Microbiology and Infectious Diseases Wytemaweg 80 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"van de Sande","sequence":"additional","affiliation":[{"name":"ErasmusMC Department of Medical Microbiology and Infectious Diseases Wytemaweg 80 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key\n\t\t\t\t20180423081436_bib1","doi-asserted-by":"crossref","first-page":"e0004244","DOI":"10.1371\/journal.pntd.0004244","article-title":"Mycetoma: a long journey from neglect","volume":"10","author":"Zijlstra","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180423081436_bib2","doi-asserted-by":"crossref","first-page":"e2550","DOI":"10.1371\/journal.pntd.0002550","article-title":"Global burden of human mycetoma: a systematic review and meta-analysis.","volume":"7","author":"Van de Sande","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180423081436_bib3","doi-asserted-by":"crossref","first-page":"e3218","DOI":"10.1371\/journal.pntd.0003218","article-title":"Mycetoma medical therapy","volume":"8","author":"Welsh","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180423081436_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.trstmh.2012.07.003","article-title":"Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan.","volume":"106","author":"Zein","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180423081436_bib5","article-title":"FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems","author":"FDA","journal-title":"Drug Safety Communications"},{"key":"key\n\t\t\t\t20180423081436_bib6","article-title":"European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole","author":"EMA"},{"key":"key\n\t\t\t\t20180423081436_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0035-9203(84)90126-3","article-title":"Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii","volume":"78","author":"Mahgoub","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180423081436_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","article-title":"The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis","volume":"105","author":"Fahal","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180423081436_bib9","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.01045-10","article-title":"In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine","volume":"55","author":"van Belkum","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.49.4.1364-1368.2005","article-title":"Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method","volume":"49","author":"van de Sande","year":"2005","journal-title":"Antimicrob. Agents Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib11","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/AAC.01546-09","article-title":"Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents","volume":"54","author":"van de Sande","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib12","doi-asserted-by":"crossref","first-page":"e0003926","DOI":"10.1371\/journal.pntd.0003926","article-title":"A Madurella mycetomatis grain model in Galleria mellonella larvae","volume":"9","author":"Kloezen","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180423081436_bib13","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","article-title":"In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay","volume":"48","author":"Ahmed","year":"2004","journal-title":"Antimicrob. Agents. Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-4632.2004.02392.x","article-title":"Clinical efficacy and safety of oral terbinafine in fungal mycetoma","volume":"45","author":"N\u2019Diaye","year":"2006","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t20180423081436_bib15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4269\/ajtmh.2006.75.1106","article-title":"Successful treatment of black-grain mycetoma with voriconazole","volume":"75","author":"Loulergue","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180423081436_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","article-title":"Posaconazole treatment of refractory eumycetoma and chromoblastomycosis","volume":"47","author":"Negroni","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"key\n\t\t\t\t20180423081436_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2012.01.015","article-title":"Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection","volume":"887\u2013888","author":"Wissen","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key\n\t\t\t\t20180423081436_bib18","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4081\/ejh.2014.2428","article-title":"A histological procedure to study fungal infection in the wax moth Galleria mellonella","volume":"58","author":"Perdoni","year":"2014","journal-title":"Eur J Histochem"},{"key":"key\n\t\t\t\t20180423081436_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.idc.2006.06.007","article-title":"Pharmacokinetics and pharmacodynamics of antifungals","volume":"20","author":"Andes","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180423081436_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-3164.2011.00985.x","article-title":"Terbinafine pharmacokinetics after single dose oral administration in the dog","volume":"22","author":"Sakai","year":"2011","journal-title":"Vet Dermatol"},{"key":"key\n\t\t\t\t20180423081436_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0035-9203(62)90143-8","article-title":"Chemotherapy of maduromycosis. I. Preliminary experiments with diamidinodi-phenylamine dihydrochloride and amphotericin B in vivo and in vitro","volume":"56","author":"Murray","year":"1962","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180423081436_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-8244(03)00096-8","article-title":"A murine model of Madurella mycetomatis eumycetoma","volume":"37","author":"Ahmed","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"key\n\t\t\t\t20180423081436_bib23","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bjd.14025","article-title":"Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice","volume":"173","author":"van de Sande","year":"2015","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20180423081436_bib24","doi-asserted-by":"crossref","first-page":"e3232","DOI":"10.1371\/journal.pntd.0003232","article-title":"Last generation triazoles for imported eumycetoma in eleven consecutive adults","volume":"8","author":"Crabol","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180423081436_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.medmal.2013.06.004","article-title":"Management of mycetomas in France.","volume":"43","author":"Mattioni","year":"2013","journal-title":"Med Mal Infect"},{"key":"key\n\t\t\t\t20180423081436_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clindermatol.2011.09.009","volume":"30","author":"Estrada","year":"2012","journal-title":"Eumycetoma. Clin Dermatol"},{"key":"key\n\t\t\t\t20180423081436_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/8.4.299","article-title":"Pharmacokinetics of ketoconazole in normal subjects","volume":"8","author":"Daneshmend","year":"1981","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib29","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.32.9.1310","article-title":"Pharmacokinetics of itraconazole following oral administration to normal volunteers","volume":"32","author":"Hardin","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib30","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/jac\/dkt229","article-title":"Steady-state pharmacokinetics and metabolism of voriconazole in patients","volume":"68","author":"Geist","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.01034-08","article-title":"Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers","volume":"53","author":"Krishna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180423081436_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AAC.02006-13","article-title":"Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model","volume":"58","author":"Dolton","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/56\/4\/469\/24702683\/myx064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:38:28Z","timestamp":1569980308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/56\/4\/469\/4158469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myx064","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2017,9,14]]}}}